With the increase in the number of patients with diabetes on the rise, there is a corresponding increase in Diabetes-related Retinopathy. In 2012 it was estimated over 93 million were suffering from some form of eye damage caused by diabetes worldwide 19. By 2015 this figure rose to 145 million, with 45 million people with diabetes suffering from Proliferative Diabetes-related Retinopathy (PDR) which is the advanced sight threatening form of Diabetes-related Retinopathy.
The Diabetes-related Retinopathy Barometer Study across 41 countries reported a frequency of Diabetes-related Retinopathy prevalence of 41% in South East Asia region, 20% in the European region, 19% in the Americas regions and Western Pacific region, 18% in the Eastern Mediterranean region and 12% in the Africa region. (ref The Diabetes-related Retinopathy barometer report:global findings 2017). Diabetes-related Macular Edema prevalence was found to be 11% in the Eastern Mediterranean region, 9% in the European region, 6% in the Americas regions, Western Pacific region, and South East Asia region, and 0% in the Africa region.
|Region/Country||% Diabetics diagnosed with
|% Diabetics diagnosed with
Diabetes-related Macular Edema
|Eastern Mediterranean Region||18||11|
|United Arab Emirates||26||9|
|Region of the Americas||19||6|
|South East Asia Region||41||6|
|Western Pacific Region||19||6|
Diabetes-related Retinopathy was more frequent in respondents with type 1 (25%) versus type 2 (16%) diabetes, whereas there was little variation in reported Diabetes-related Macular Edema for those with type 1 (8.1%) and type 2 (7.7%) diabetes.